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Dendritic cells are key linkers of innate and adaptive immunity. Efficient dendritic
cell activation is central to the acquisition of immunity and the efficacy of vaccines.
Understanding how dendritic cells are affected by Plasmodium falciparum blood-stage
parasites will help to understand how immunity is acquired and maintained, and
how vaccine responses may be impacted by malaria infection or exposure. This
study investigates the response of dendritic cells to two different life stages of the
malaria parasite, parasitized red blood cells and merozoites, using a murine model.
We demonstrate that the dendritic cell responses to merozoites are robust whereas
dendritic cell activation, particularly CD40 and pro-inflammatory cytokine expression,
is compromised in the presence of freshly isolated parasitized red blood cells. The
mechanism of dendritic cell suppression by parasitized red blood cells is host red
cell membrane-independent. Furthermore, we show that cryopreserved parasitized red
blood cells have a substantially reduced capacity for dendritic cell activation.
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INTRODUCTION
Dendritic cells (DCs) are key linkers of innate and adaptive immunity and their activation is
essential to vaccination. Ablating DCs inmurinemodels leads to vaccination failure and subsequent
loss of antigen-specific T cells (1). Immunization of individuals living in malaria-infested regions
has been notoriously difficult, with even the most promising vaccines failing to provide high levels
of efficacy. A failure to activate DCs in people infected with Plasmodium falciparum blood-stage
parasites may provide some explanation to the low efficacy of malaria vaccines [reviewed in (2)]. It
may also explain the slow acquisition of natural anti-malarial immunity in individuals residing in
malaria-endemic settings.
Activation of DCs is required for their subsequent efficient activation of T cells. Activated DCs
increase surface expression of the co-stimulatory markers MHCII, CD40, CD80, and CD86, which
are all involved in T cell co-stimulation. In particular, the interaction between CD40 on DC and its
ligand CD40L on T cells is integral to enhance both T cell and DC responses for effective adaptive
immune responses (3).
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There remains an unresolved question of whether exposure
to P. falciparum inhibits DC activation, leading to DC
“suppression.” Literature from ex vivo studies has suggested
that DCs from infected individuals are inhibited in core
DC functions, namely: expression of co-stimulatory markers,
cytokine secretion, antigen uptake, and the ability to induce
primary and secondary T cell responses (4–7). However, there
is a lack of consensus among in vitro studies as to what effect
P. falciparum has directly upon DCs. To date the majority of
literature has examined DC responses to parasitized erythrocytes
(pRBCs), the intracellular stage of the asexual parasite. In this
life stage P. falciparum is concealed from host immunity by the
host erythrocyte membrane, though parasite proteins such as the
adhesion ligand PfEMP1 are exported to the erythrocyte surface.
Very little research into cellular responses to the infectious
extracellular stage, known as the merozoite, has been carried out.
Furthermore, it is important to note that the majority of in vitro
studies have been carried out in monocyte-derived (mo) DCs (8),
which are phenotypically and functionally different from bona
fide DCs (8, 9).
The murine Flt3 ligand-induced DCs (FL-DCs) closely
recapitulate the DCs of the blood, similar to spleen DC, but
slightly less mature conventional (cDC) and plasmacytoid (pDC)
DC subsets (10–13). Therefore, the FL-DC model was used here
for its ease and its capacity to generate large volumes of bona fide
DCs, enabling us to test a broad variety of parameters.
The FL-DC cDCs can be divided into two subsets by
expression of CD24 and CD11b. The FL-DC CD24+ cDCs
(CD24+CD11b−) are immature cDC1. The cDC1 subset is
specialized in cross-presentation and has a superior ability to
prime naive cytotoxic CD8+ T cells, and polarize T cells toward
the TH1 pathway via IL-12 production. Meanwhile, the FL-
DC CD11b+ subset (CD24−CD11b+) is equivalent to immature
cDC2 (11). These FL-DC cDC1 and cDC2 populations share
many pattern recognition receptors with their human blood DC
counterparts and the core surface phenotypes and functions of
cross-presentation (cDC1) and bacterial recognition and CD4+
T cell stimulation (cDC2) are conserved [reviewed in Macri
et al. (14)].
In contrast, pDCs are overall poor stimulators of T cell
responses and do not upregulate co-stimulatory markers. Their
defining characteristic is the secretion of Type I and III
interferons (IFNs) in response to viral infection and/or the
ligation of endosomal TLRs (15–17). In humans, pDCs are also
the only subset to express TLR9, which is a known receptor for
malarial DNA (18, 19).
Previous literature has described pDC production of IFN-α
in response to P. falciparum merozoites in vitro (19) and during
natural infection in humans (20), where pDCs appear suppressed
in the presence of malaria parasites (21). Further studies hinted
at pDC as a source of replicating malaria parasites (22), but this
subset has, overall, been poorly studied in malaria.
This study aimed to identify how DC responses to the
pRBC and the merozoite differ, with findings indicating that
merozoites induce DC activation whereas pRBCs induce low co-
stimulatory marker expression but high production of cytokines,
with greater suppression at increasing doses of pRBCs. We reveal
that the mechanism of suppression of DC activation occurs
independently of the host RBC membrane, is not seen with
pRBCs that have undergone a freeze-thaw cycle, and cannot be
rescued by merozoites nor an exogenous TLR9 stimulus.
METHODS
Culture, Purification, and Freeze-Thawing
of P. falciparum Blood-Stage Parasites
Plasmodium falciparum 3D7 parasites were cultured as per
standard protocols. Briefly, parasites were maintained in
RPMI1640 (Gibco) enriched with 5% Albumax (Gibco) and 5%
AB+ human serum obtained from the Red Cross, Melbourne,
Australia. Parasites were cultured at 3–5% haematocrit using
type-O negative blood (Red Cross) and incubated in medical
gas (1% O2 and 5% CO2 in nitrogen gas) at 37
◦C as per
standard protocols. Parasite growth was assessed daily by thin
smear (23) stained with Giemsa’s azur eosin methylene blue
solution (Merck Millipore). Parasites were sorbitol synchronized
(24) and selected for knob expression by gelatin flotation (25).
All parasites were initially treated with Mycoplasma removal
agent (MP Biomedicals) for 2 weeks as per the manufacturer’s
instructions. Subsequently, parasites were tested at 1-monthly
intervals for Mycoplasma contamination using the MycoAlert
test kit (Lonza).
Trophozoite Preparation
Trophozoites at 24–28 h post-invasion were isolated by magnetic
selection with the VarioMACS (Miltenyi Biotech) system. Purity
was assessed by counting 200 cells via Giemsa thin smear.
Preparations varied from 70 to 99% parasite purity and
preparations with purity of <90% were re-purified by repeating
magnet selection. Purified preparations were counted using
a haemocytometer and resuspended to the appropriate cell
concentration in complete medium (CM): RPMI1640 containing
GlutaMAX (Gibco) supplemented with 10% heat-inactivated
FCS, 0.1mM 2-beta-mercaptoethanol, 100 U/mL penicillin
and 100µg/mL streptomycin. Aliquots of purified trophozoites
with >95% purity were also frozen in glycerolyte 57 (Baxter
Healthcare Corporation) and stored at −80◦C to compare
efficacy of DC stimulation with same-day isolated cultures.
Merozoite Preparation
Merozoites were purified as per Boyle et al. (26). Briefly, late-
stage (30–34 h) trophozoites were purified and returned to
culture without uninfected RBCs (uRBCs). When trophozoites
had matured into schizonts (40 h), 10µM of protease inhibitor
E64 (Sigma) was added to culture medium to inhibit merozoite
egress. Upon maturation into late-stage schizonts (46–48 h),
pRBCs were resuspended in 20mL of RPMI-HEPES and schizont
rupture was induced by pushing through a 1.2µM syringe
filter (Pall), resulting in purified merozoites. Merozoites were
stained with ethidium bromide (EtBr) and counted by flow
cytometry. For storage, late-stage segmented schizonts derived
by this method were frozen in PBS at a concentration of 150 ×
107/mL after arrest with E64 but prior to filter lysis and stored at
−80◦C until use in assays.
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Saponin Lysis to Remove Host RBC
Membranes
Magnet-purified pRBCs or empty “mock” tubes were co-
incubated with 0.09% saponin in 1X PBS for 30 s at RT, after
which they were washed three times in RPMI containing 2% FCS
to remove residual saponin. Saponin lysis of host RBCmembrane
was confirmed by microscopy. Both saponin-treated and intact
parasites were then resuspended in CM and co-incubated with
FL-DCs in the presence or absence of 0.5µM CpG2216. CM or
CM and CpG2216 were added to “mock” tubes to control for
any potential carry-over of the detergent and added to FL-DCs
as separate controls.
FL-DC Culture
Bone marrow cells were stimulated with Flt3-L to induce large
quantities of DCs similar in phenotype and function to those
found in murine spleen (11, 12, 27) (Supplementary Figure 1).
Briefly, FL-DCs were obtained as follows: leg bones of
C57Bl/6 mice (AMREP Animal Services Precinct Animal Centre,
Melbourne, Australia) were dissected out and harvested into
RPMI containing 2% v/v FCS. Bones were cut open and bone
marrow was flushed with a 22 g needle using 2mL of RPMI-FCS
per bone. After centrifugation at 600× g for 7min, cells were co-
incubated with 1mL of red cell lysis buffer (Sigma) with constant
mixing for 30 s. Cells were washed twice in RPMI1640 containing
2% FCS before resuspending in complete medium and filtering
through a 70µM sieve (Falcon). Cells were resuspended at 1.5×
106 cells/mL in complete medium containing 100 ng/mL of Flt3-
L-Ig (BioXCell) and cultured in vented cap tissue culture flasks
(Corning) in a 37◦C incubator in 5% CO2 for 8 days.
Determining the Effect of the Parasite-DC
Ratio Upon the DC Response to Purified
Blood-Stage P. falciparum
After 8 days culture FL-DC were counted and washed in CM.
Merozoites and pRBCs were titrated against FL-DCs in round-
bottom 96-well-tissue culture plates (Falcon) at a final cell
concentration of 0.5 × 106 FL-DC/mL. Additionally, FL-DCs
were also cultured with 0.5µM CpG2216 alone or in addition to
parasites, or with media alone or uRBCs as negative controls. All
incubations were carried out for 18–20 h at 37◦C in 5% CO2.
Flow Cytometric Analysis
For analysis of surface phenotype, cells were stained in 1X PBS
supplemented with 2% v/v FCS and 10% v/v 0.1M EDTA (MACS
buffer) with monoclonal antibodies for MHCII, CD11b, CD11c,
CD24, CD45R, and CD199. For staining, antibody was diluted
in MACS buffer and antibody cocktail was added at 10µL/106
cells, with a minimum of 30 µL of cocktail per well or tube, and
incubated in the dark at 4◦C for 20min. Cells were washed to
remove unbound antibody and analyzed on a BD Fortessa or
BD LSRII flow cytometer. DCs were identified as medium-sized
cells on forward and side scatter and doublets and PI-positive
dead cells excluded. Activation of viable DCs was measured
by expression of costimulatory markers MHCII, CD40, CD69,
CD80, and CD86 on each DC subset using antibodies outlined
in Supplementary Table 1.
Cytokine Analysis
Frozen supernatants derived from parasite-FL-DC co-culture
experiments were tested for the presence of IFN-γ, IL-1β, IL-
2; IL-4, IL-5, IL-9, IL-12p70, IL-13, IL-17a, IL-18, IL-22, IL-
23, IL-27, GM-CSF, IP-10, eotaxin, and MIP-1α by ProcartaPlex
(eBioscience) multiplex as per manufacturer’s instructions.
Presence of MIP-2, IL-6, IL-10, GRO-α, MCP-1, MCP-3, MIP-
1β, RANTES, and TNF-α were assayed for by both FlowCytomix
(eBioScience) and ProcartaPlex. Expression of IFN-α and IFN-β
was measured by a separate multiplex (ProcartaPlex).
RESULTS
The Ratio of pRBCs-to-DCs Affects
Expression of DC Maturation Markers and
This Is Not Rescued in the Presence of
TLR9 Ligand
People in endemic malaria regions can have a wide range
of parasitemia in peripheral blood. Those with asymptomatic
malaria typically have lower levels of parasitemia, ∼5,000 P.
falciparum parasites per mL of peripheral blood on average
(28), depending on the setting. This equates to a ratio of ∼0.25
parasites to 1 DC in blood. However, significant numbers of
asymptomatic people and those with symptomatic malaria have
infections over 106 parasites per mL, equating to ∼50:1 ratio of
parasites to blood DC (29, 30).
To model the effect of different parasite concentrations on
blood DC we analyzed the response of murine FL-DC to purified
pRBCs from a high ratio of 50:1 to a low ratio of 1:1. In
replicate, CpG2216 was added to the cultures to ask whether
the presence of pRBCs affected the activation of FL-DC by an
additional stimuli. The addition of uRBC alone were used to
control for responses to RBC alone. To determine cell activation,
MHCII and CD40 and CD86 co-stimulation molecule expression
was measured upon FL-DCs (Figure 1). Analyses of total FL-
DC indicated a reduction in CD40 expression at ratios of
pRBC:DC of>12.5, and at lower concentrations in the additional
presence of TLR9 ligand (CpG2216). Separate analyses of cDC
and pDC subsets indicated that high pRBC concentrations led
to a significant reduction of co-stimulation marker expression
on both CD24+ and CD11b+ cDCs (Figure 1C) that was
particularly strong for CD40, and also occurred in the additional
presence of CpG2216 (Figure 1A). While DC viability decreased
in response to 50:1 concentrations of pRBC alone, viability was
not significantly decreased by pRBC in the presence of CpG yet
co-stimulation molecule expression still decreased (Figure 1B).
In response to low ratios of pRBCs of <12.5 pRBC:DC, cDC
expression of co-stimulatory markers was comparable to that
induced by CpG2216.
A more complex relationship between MHCII and co-
stimulatory marker expression and pRBC ratio was observed
in pDCs. Upon stimulation with low ratios of pRBC, pDCs
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FIGURE 1 | High doses of pRBCs induce poor FL-DC activation and prevent normal TLR9-mediated activation. (A) Expression of CD40 on CD24+ cDCs was
downregulated in response to high doses of pRBCs alone (solid circles) or pRBCs + CpG2216 (hollow circles). Responses to CpG2216 alone (solid line) and uRBC
alone (dashed line) are shown for comparison. (B) Viability of total FL-DCs in response to pRBCs alone (gray) or pRBCs + CpG2216 (black). Viability in response to
culture medium alone (CM; white with gray border) or CpG2216 alone (CpG; gray with black border) are shown for comparison. (C) Expression of MHCII, CD40, and
CD86 in response to pRBCs in CD24+ cDC, CD11b+ cDC, and pDCs. Co-stimulatory marker expression is shown in response to pRBC-to-DC ratios of 50:1 (black),
6:1 (gray), and 1:1 (white), as well as in response to CpG2216 (solid line) or uRBCs (dashed line). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. P-values were
determined by two-way ANOVA using multiple comparisons. Data shown is from three experiments, each experiment using pooled FL-DC cultures from two mice.
Error bars represent SEM of three separate experiments. MFI—geometric mean fluorescence intensity.
expressed MHCII, CD40, and CD86 at elevated levels compared
to uRBCs alone, which could be further elevated in the presence
of CpG2216. However, upon stimulation of pDC with pRBC
ratios >25:1, in the presence or absence of CpG2216, CD40, and
CD86 expression was reduced whereas MHCII (Figure 1C) and
CD80 (data not shown) expression increased to levels above that
seen with CpG2216 alone.
The Ratio of pRBCs-to-DCs Alters FL-DC
Patterns of Cytokine Production Including
in the Presence of TLR9 Ligand
The data of Figure 1 indicated that at high pRBC:DC ratios, the
response of DCs to CpG2216 was inhibited and that overall, DC
activation was suppressed. To further investigate the activation
of DC across a range of pRBC concentrations we analyzed the
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production of cytokines in the supernatants of the cultured
FL-DC.
Others have previously reported pDC-produced IFN-α in
response to P. falciparum (19, 31, 32), with conflicting reports
on whether the activation of pDCs was inhibited by pRBCs
(19, 32). In the FL-DC cultures with pRBCs alone, IFN-α was
only detectable in the cultures at ratios of <12.5 parasites per DC
(Figure 2A). At pRBC:DC ratios of 1:1 and 6:1, we detected high
levels of IL-6 and IP-10 (CXCL10) and detectable levels of TNF-α,
IL-10, IFN-γ, and MIP-2 (CXCL2, Figure 2B). At pRBC-to-DC
ratios of 50:1, IL-6, TNF-α and IL-10 production were reduced
to the baseline levels induced by uRBCs whilst IP-10, IFN-γ and
MIP-2 were produced at levels similar to those observed with
ratios of 1:1 pRBC:DC (Figure 2B).
We then investigated whether cytokine secretion to pRBCs
was boosted in the presence of TLR9 ligand, CpG2216, or
if pRBCs were able to suppress CpG2216-induced cytokine
secretion. The pDC and pDC-like cells are the only cells capable
of producing high levels of IFN-α to CpG oligonucleotides,
potent TLR-9 ligands (33). Addition of CpG2216 to pRBC-
DC co-incubations increased overall cytokine secretion
but a pRBC dose-dependent suppression of TLR9-induced
IFN-α, i.e., pDC responses, was observed (Figure 2A) from
bulk cultures. Reduced production of both TNF-α and IL-
10 were also observed with pRBC:DC ratios of 6:1 and
above (Figure 2). This suppression was marked at pRBC:DC
ratios of 50:1 for IL-10, TNF-α, IL-6, and MIP2 production
(Figure 2B).
Only Freshly Isolated pRBCs Are
Suppressors of FL-DC Activation
We compared responses of FL-DCs stimulated with freshly
isolated pRBCs and pRBCs previously purified and freeze-
thawed. The protocol used for cryopreservation and thawing
of pRBCs largely preserves pRBC integrity (34, 35) and is
a convenient way of preparing standardized preparations of
parasites for research, including experimental human infections
(36, 37). However, frozen pRBCs were less efficient at activating
the FL-DC (Figure 3A and data not shown). Moreover, they
were inefficient at suppressing the TLR-9 activation of FL-
DC compared to the freshly isolated pRBC (Figure 3A and
Supplementary Figure 2). Therefore, frozen and fresh pRBC
preparations were qualitatively different in their fundamental
abilities to activate DCs.
Removal of Host RBC Membrane Does Not
Prevent Parasite-Induced Suppression of
DC Responses
The differences in the ability of fresh vs. frozen and thawed
pRBC preparations to affect FL-DC activation suggested that
perhaps a reduction in pRBC membrane viability was the
cause. To test this, we treated freshly isolated pRBCs with the
detergent saponin. Saponin treatment of pRBCs disrupts the RBC
membrane and the parasitophorous vacuolar membrane (38).
Thus, saponin-treated trophozoites lack expression of malarial
proteins normally located on the host red cell membrane,
including molecules such as PfEMP1 which have been postulated
to inhibit innate immune responses (39–41).
Co-stimulatory marker expression by DCs was similar
after stimulation with saponin-treated and untreated pRBCs,
with pRBC:DC ratios of 1:1 and 5:1 actually inducing
lower levels of activation whilst high doses still led to low
CD40 upregulation. In the presence of CpG2216, DCs were
similarly activated, regardless of saponin treatment, whilst
high doses of saponin-treated pRBC still suppressed the
CpG2216-driven CD40 (Figure 3) and CD86 upregulation
(Supplementary Figures 3B,C) on cDC and pDC populations.
Thus, neither the presence of host RBC membrane nor
surface-expressed parasite proteins, including PfEMP1, appeared
to play a major role in suppression of FL-DC activation
in the presence of high levels of parasites. Viability was
comparable between FL-DCs exposed to saponin-treated
and non-treated pRBCs for every ratio of pRBCs to DCs
(Supplementary Figure 3A). This data also suggested that
the differences in DC activation abilities between frozen and
freshly isolated pRBC were intrinsic to the trophozoite and not
dependent on the host RBC membranes.
Merozoites Are Potent Stimulators of
FL-DCs
Merozoites are the extracellular life stage of the malaria parasite.
FL-DCs stimulated with ratios of merozoites to DCs from a
high ratio of 50:1 to a low ratio of 1:1 were, in the main,
highly activated, with dose-dependent increases of all surface
activation markers examined (Figure 4), although CD11b+ FL-
DC showed reducedMHCII expression with high concentrations
of merozoites (Figure 4C). However, in contrast to stimulation
with pRBCs, at ratios higher than 12.5 merozoites:DC significant
DC death was observed (Figure 4B). The rate of cell death
at these ratios was high, consistent with excessive activation,
and while cell surface activation of the remaining DC by
TLR9 ligand was largely not perturbed by high concentrations
of merozoites (Figure 4C), these results should be viewed in
light of the very high rates of DC death at these parasite
ratios.
FL-DC Production of Cytokines in
Response to Merozoites Generally
Increases With Higher Merozoite Dose
In response to increasing doses of merozoites, FL-DCs produced
increasing amounts of cytokines (Figures 5A,B). This was
inverse to the effect observed with pRBCs (Figure 2). Merozoites
were a potent stimulus for IFN-α production. In the presence
of CpG2216, production of TNF-α and IL-6 was reduced
with increasing merozoites, potentially due to high merozoites
concentrations inducing high DC death (Figure 4B). Overall,
merozoites appeared to be potent activators of FL-DCs,
inducing high levels of cell death at the highest concentrations
but apparently not suppressing FL-DC activation by TLR9
ligands.
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FIGURE 2 | Production of cytokines by FL-DCs is inhibited by high pRBC-to-DC ratios. Supernatants from FL-DC cultures stimulated with pRBCs were assayed for
cytokine production using FlowCytomix and ProcartaPlex multiplexes. (A) IFN-α expression by FL-DCs was suppressed by the presence of high ratios of pRBCs,
even in the presence of TLR9 ligand (pRBC+CpG). (B) FL-DC production of cytokines in response to pRBC-to-DC ratios of 1:1 (white), 6:1 (gray), and 50:1 (black)
alone, or in the presence of CpG2216. Cytokine expression in response to uRBCs (dashed line) or CpG2216 alone (solid line) are included for comparison. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001. P-values were determined by two-way ANOVA using multiple comparisons. Data shown is from three experiments with
each experiment using pooled FL-DC cultures from two mice. Error bars represent SEM of three separate experiments.
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FIGURE 3 | pRBC-induced suppression is dependent on fresh parasites but not on intact host RBC membranes. (A) A titration of frozen pRBCs were compared to
freshly purified pRBCs for the ability to induce activation and parasite-induced suppression of FL-DC TLR9 responses. Shown are IFN-α responses either to parasites
alone or in the additional presence of CpG2216. (B) FL-DCs were co-incubated with saponin-treated or untreated P. falciparum pRBCs for 18–20 h at three different
parasite-to-DC ratios: 1:1 (white), 5:1 (gray), and 25:1 (black), in the presence or absence of CpG2216. DC subpopulations were gated and expression of CD40 is
shown. Each bar shows the SEM of three separate experiments, with each experiment using FL-DC cultures derived from pooling two mice. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001. P-values were determined by two-way ANOVA using multiple comparisons. (C) To control for effects of any carry-over saponin, saponin
was also added to empty tubes and washed alongside the pRBC samples. Culture medium alone or medium containing CpG2216 were aliquoted into these tubes
(designated Saponin +) and used to stimulate FL-DCs. The lack of any suppression of CD40 expression by uRBCs alone (25:1) is shown.
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FIGURE 4 | Merozoites induce potent activation but high cell death of FL-DC. (A) Surface expression of CD40 on CD24+ cDCs in response to 1–50 merozoites per
DC (solid triangles) or in the additional presence of CpG2216 (hollow triangles). Level of CD40 in response to CpG2216 alone (solid line) and media alone (dotted line)
are shown for comparison. (B) Exposure to high doses of merozoites results in death of up to 90% of FL-DCs after 18 h culture. Viability in response to culture
medium alone (CM; white with gray border) or CpG2216 alone (CpG; gray with black border) are shown for comparison. (C) MHCII, CD40 and CD86 surface
expression on FL-DCs gated for CD24+, CD11b+ or pDC in response to 1:1 (white bars), 6:1 (gray bars), or 50:1 (black bars) merozoites:DC, alone or in the addition
presence of CpG2216.). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. P-values were determined by two-way ANOVA using multiple comparisons. Data shown
is from three experiments, each experiment using pooled FL-DC cultures from two mice. Error bars represent SEM of three separate experiments.
Merozoites Cannot Rescue FL-DC
Suppression Induced by pRBCs
During malaria infection DCs would encounter both trophozoite
and merozoite life-stages of the malaria parasite. Since
merozoites did not suppress DC activation we tested whether
merozoites would rescue the upregulation of CD40 in the
presence of pRBCs, with or without TLR9 ligand. A ratio of 25
pRBCs:DCs was used with the addition of equal numbers of
merozoites. Ratios of 25 parasites per DC for each life stage were
chosen as concentrations that were still inhibitory for pRBCs
(Figure 1A) but maintained high CD40 levels in response to
merozoites alone (Figure 4A). Whilst merozoites are potent
stimulators of MHC and co-stimulatory molecule expression
on FL-DCs (Figure 4), they were unable to efficiently activate
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FIGURE 5 | Merozoites induce expression of a range of cytokines from
FL-DCs. FL-DCs were incubated for 18 h with merozoites (Mz) and cytokines
were measured in the supernatant using FlowCytomix and ProcartaPlex
multiplexes. (A) High ratios of Mz:DCs induce high expression of IFN-α.
(B) Mz:DC ratios of 1:1 (white bars), 6:1 (gray bars), or 50:1 (black bars). The
expression in response to media alone (dotted line) and CpG2216 alone (solid
line) were included for comparison. *p < 0.05, **p < 0.01. P-values were
determined by two-way ANOVA using multiple comparisons. Figure shows
pooled data from three experiments of FL-DC cultures derived from two mice
each.
FL-DCs in the presence of pRBCs, particularly the upregulation
of CD40 (Figure 6), either when mixed with pRBCs alone or in
the additional presence of CpG2216 (Figure 6).
DISCUSSION
We have shown that at doses of >6 parasites to 1 DC,
P. falciparum pigmented trophozoites possess a stage-specific
capacity to suppress specific DC functions. This suppressive
capacity particularly affects the upregulation of CD40 on all DC
subsets and the ability of DCs to produce key cytokines; IFN-α,
TNF-α, IL-6, and IL-10. This suppressive capacity of pRBCs is not
dependent upon PfEMP1 or other parasite molecules expressed
on, or other properties of, the infected host RBC membrane
(Figure 3).
The pRBCs not only suppressed DC responses to themselves
at ratios of >6 per DC but also suppressed the ability of DCs
to respond to the potent TLR9 ligand, CpG2216 (Figure 1).
This included inhibiting the ability of pDCs to produce IFN-α
to CpG2216 (Figure 2A). Although suppressing TLR9-mediated
DC activation, increasing doses of pRBCs did not enhance
DC death. Others have previously shown that monocyte-
derived DCs, DCs fundamentally different to those investigated
herein, also do not require PfEMP1 to be suppressed, though
suppression of DC activation at doses of 100:1 were at least in part
due to DC apoptosis (42). The data shown herein of suppression
of TLR9-mediated FL-DC activation by pRBCs is independent
of cell death (Figure 1). In the aforementioned study, it was
also shown via transwell experiments that cell-cell contact was
not required for 100:1 doses of pRBCs to inhibit TLR-mediated
upregulation of HLA-DR, CD83, and CD86 (42). Similarly,
lysates from pRBCs induced chemokine production from human
DCs, similarly to intact pRBCs (32). Both suppression and
activation of DCs by pRBCs are therefore mediated by soluble
factors, which could potentially be addressed by co-incubating
TLR-stimulated DCs with conditioned parasite medium and
measuring suppression.
In stark contrast, purifiedmerozoites induced dose-responsive
activation of the FL-DCs and high (likely activation-induced)
DC death at high doses (Figures 4, 5). The merozoites were
not able to rescue the activation of FL-DCs in the presence of
pRBCs; in fact, pRBCs inhibited the strong merozoite-driven DC
activation (Figure 6). DC death in malaria is via the apoptotic
pathway (4, 42, 43), and it is unclear whether the DC death
observed in response to high ratios of parasites in this study is due
to parasites directly activating pro-apoptotic signals or whether
it is apoptosis as a natural endpoint of DC activation. The
increased DC apoptosis may inhibit activation of surrounding
DCs by impairing the maturation of immature DCs (44) and
polarizing DCs toward a tolerising phenotype (45). Regardless,
DC apoptosis is likely a major contributor to the short duration
of immune memory to malaria. Determining whether apoptosis
is driven by maturation or parasites will help to identify methods
of reducing apoptosis and improve downstream DC responses.
In contrast, ratios of 1:1 pRBC potently activated DCs to
upregulate co-stimulatory markers (Figure 1) and cytokines,
including IFN-α (Figure 3). Merozoites on the other hand,
really showed a dose response effect in their ability to activate
DC (Figures 4, 5), although ratios of 1 merozoite per DC
still activated DC, highest levels of cytokines and cell surface
markers were reached with more than 6 merozoites per DC.
As merozoites and trophozoites have divergent transcriptomes
(46, 47), this may help to identify potential activatory proteins.
Furthermore, DC activation by these very low ratios of parasites
suggests that even very low parasitaemia may induce potent DC
activation, at least initially. Asymptomatic parasitaemia, often
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FIGURE 6 | Stimulation with mixed high-dose pRBCs and merozoites in the presence or absence of CpG2216 does not result in recovery of CD40 expression.
FL-DCs were stimulated with either pRBCs alone, or pRBCs in the presence of an equivalent ratio of merozoites (Mz), in the presence or absence of CpG2216. All
pRBCs and merozoites were added at a ratio of 25 per DC. Neither the addition of merozoites nor the addition of CpG2216 resulted in rescue of CD40 expression,
but other markers demonstrated a heterogenous response. Co-stimulatory marker expression is represented as fold increase over media control and each bar
represents mean and SEM of two experiments based on pooled FL-DC cultures of two mice.
seen in areas of high transmission, may reflect a pattern where
initial potent DC-driven responses are suppressed by subsequent
high-parasitaemia infections, leading to immunosuppression and
tolerance. In contrast, low-parasitaemia infections may actually
induce potent DC responses that lead to the generation of
memory.
As regards physiological relevance of the parasite-to-DC ratios
examined in this study, there is relatively little information on
bioavailability of blood-stage malaria parasites to splenocytes in
vivo. However, in vitro studies suggest that in high-parasitaemia
settings a large proportion of merozoites fail to invade (26). This
would result in high volumes of merozoites circulating to or
being trafficked to the primary lymphoid tissues by migratory
DCs, potentially even to the 50:1 ratios reported in this study.
It is also observed in vivo that the spleen can remove parasites
from RBCs without inducing RBC lysis (48–50), and while
there is no information at what rate this occurs, splenocytes
may encounter membrane-free pRBC at a rate dependent on
overall parasite burden. Potentially, splenic DCs may encounter
very high ratios of membrane-free pRBC in high parasitaemia
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settings, and as DC responses are not significantly affected by
pRBC membrane, it is possible that the patterns reported in our
study reflect physiological phenomena occurring in lymphoid
organs.
An important point revealed in this work was that the DC
response to frozen and thawed pRBCs is distinct from the
response to fresh pRBCs (Figure 3). Methods to standardize
frozen pRBC preparations have been used to prepare parasite
vaccinations for standardization of controlled human malaria
infection trials in naïve individuals (36). While this method
induces viable parasites, it is likely that a proportion of ring-
stage trophozoites would not survive the freezing process and
may lead to induction of sub-optimal DC responses or tolerance.
Furthermore, it serves as a caution for in vitro experiments
that may use cryopreserved pRBCs as an immune stimulus. The
data shown would argue that a comparison with freshly isolated
pRBCs is needed to determine whether responses of human DCs
and other innate responses in vivo and in vitro are qualitatively
different when comparing inoculation with freeze-thawed vs.
fresh pRBC preparations.
The surface activation marker most consistently suppressed
by the presence of pRBCs, in both cDCs and pDCs, was
CD40. Ligation of CD40 is crucial as it improves DC survival
and enhances antigen presentation, therefore acting as a direct
marker for DC activation (3). The interaction of CD40:CD40L
between DCs and T cells activates both cell types and provides
a vital positive feedback loop for cytokine secretion and co-
stimulatory marker upregulation by DCs (3). Loss of CD40
on the surface of pRBC-exposed DCs could result in failure
to induce downstream co-stimulatory pathways, resulting in
overall failure of DC function. Work by Mukherjee and
Chauhan highlights the importance of CD40 signaling for
upregulation of other co-stimulatory markers in the moDC:P.
falciparum context. When CD40L was added to moDCs co-
incubated with “suppressive” doses of pRBCs, expression of
CD83 was unaltered and expression of CD80 enhanced, rather
than suppressed (51). A similar mechanism may be present
in bona fide DCs. If CD40 expression is restored in DCs
exposed to high doses of P. falciparum, it may restore their
ability to stimulate T and B lymphocytes, which has implications
for the design of next generation vaccine adjuvants that
either target pRBC mechanisms of CD40 down-regulation
or independently lead to enhanced expression of CD40 on
DCs.
Murine FL-DC were used as a model for human blood
DCs as they could be easily generated in large numbers
and consistently produce similar levels of pDCs and cDCs
(Supplementary Figure 4). FL-DCs also show greater
transcriptomic similarities to their human counterparts
than moDCs, another model commonly used to study
malaria-DC interactions (9). The major difference between
murine FL-DCs and human blood DCs is that only pDCs
in humans express TLR9 (52). However, findings in human
moDCs, which also do not express TLR9, are also suppressed
by high doses of pRBCS (42, 53), suggesting high pRBC
doses can suppress DC activation by multiple alternate
pathways.
The mechanism by which pRBCs inhibit DC activation
remains unclear. The effects of hemozoin upon DCs have
been debated in the literature (18, 19) but it is unlikely
to be the suppressive factor in this model as merozoite
preparations were not hemozoin-depleted prior to DC co-
incubation, yet still induced potent DC activation. A possible
explanation may be found in the proteomic and transcriptomic
differences between pRBCs and merozoites. The merozoite
transcriptome is 45% smaller than that of the trophozoite.
Merozoites lack the expression of many proteins required for
hemoglobin digestion, protein export, and parasite metabolism
(46, 47). One of these trophozoite-restricted protein families
may contain the factor responsible for suppression; alternately,
it may be a lipid, RNA byproduct or metabolite of the
pigmented trophozoite, which is a very metabolically active
life stage.
In conclusion, we demonstrate that pRBCs can suppress
specific key DC functions and activation, in contrast to the
activatory effect of merozoites. While DCs would interact with
both merozoites and pRBCs in the blood, the specific suppressive
effect of pRBCs appeared dominant and occurred even in
the presence of merozoites. These findings may help partly
explain why malaria immunity is typically slow to be acquired
through natural exposure, why vaccine efficacy and vaccine-
induced immune responses are lower in malaria endemic settings
than among malaria-naïve subjects (54), and why immunity to
malaria is generally not well-maintained (55). Further research to
understand the mechanistic basis for these effects and identifying
strategies to overcome them may be crucial for the development
of highly efficacious and long-lasting vaccines.
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